Cardiovascular disease

Precision Medicine in Cardiovascular Disease: Genetics and Impact on Phenotypes: JACC Focus Seminar 1/5 – Chris Semsarian et al.

2021-07-16T14:03:33+10:00Cardiovascular disease, Genetic testing, Publications|

Our understanding of the genetic basis of cardiovascular diseases (CVDs) has evolved rapidly. This has resulted from a combination of dedicated research in well phenotyped CVD patients, the sequencing of the human genome, and the ready accessibility and decreasing cost of next-generation sequencing technologies. This [...]

The potential for overdiagnosis and underdiagnosis because of blood pressure variability: a comparison of the 2017 ACC/AHA, 2018 ESC/ESH and 2019 NICE hypertension guidelines

2023-01-11T15:18:20+11:00Clinical guidelines, Hypertension, Publications|

Overdiagnosis causes well people to be labelled as abnormal or diseased with possible adverse psychosocial and financial consequences, and usually results in overtreatment with possible physical harms. It may occur because of overdetection because of increased sensitivity of a new test, and/or overdefinition because of [...]

Why We Might Not Need to Stress About Ruling Out Inducible Myocardial Ischemia – Katy Bell, Christopher Semsarian, Jenny Doust

2020-03-23T19:25:32+11:00Cardiovascular disease, Publications|

In patients with symptoms of stable angina, cardiac stress testing and angiography have been recommended to evaluate for inducible myocardial ischemia and obstructive coronary artery disease (CAD). Walter and colleagues investigated whether high-sensitivity cardiac troponin (hs-cTn) tests could be introduced in this diagnostic pathway.

Screening children at risk for hypertrophic cardiomyopathy: balancing benefits and harms – Christopher Semsarian & Carolyn Ho

2019-07-26T10:25:44+10:00Cardiovascular disease, Genetic testing, Publications|

Hypertrophic cardiomyopathy (HCM) is a primary myocardial disorder which can present at any age. Although the prevalence is estimated to be 1 in 500 in adults, it is far less common in young children. HCM is frequently caused by pathogenic variants in the sarcomere genes [...]

A systematic review and meta-analysis of the prevalence of left ventricular non-compaction in adults – Samantha B Ross et al.

2019-06-07T14:22:25+10:00Cardiovascular disease, Publications, Tests|

The prevalence of LVNC is higher than expected for a rare disease in all population cohorts. There are at least three major factors which appear to strongly influence the high prevalence of LVNC including the type of imaging modality used, the characteristics of the cohort [...]

Recognizing the Potential for Overdiagnosis: Are High-Sensitivity Cardiac Troponin Assays an Example? – Katy Bell et. al.

2019-02-08T10:51:45+11:00Publications, Tests, Troponin|

Overdiagnosis occurs when persons are labeled with a technically correct diagnosis that does not improve health outcomes. It is a common unintended consequence of early disease detection in asymptomatic persons but also takes place in persons with mild or ambiguous symptoms. Despite initiatives to prevent [...]

Is the “Heart Age” Concept Helpful or Harmful Compared to Absolute Cardiovascular Disease Risk? An Experimental Study – Carissa Bonner et. al.

2019-02-08T10:45:04+11:00Cardiovascular disease, Health literacy, Publications|

Cardiovascular disease (CVD) prevention guidelines are generally based on the absolute risk of a CVD event, but there is increasing interest in using ‘heart age’ to motivate lifestyle change when absolute risk is low. Previous studies have not compared heart age to 5-year absolute risk, [...]

Go to Top